PHARMACYTE BIOTECH, INC. Increase (Decrease) in Derivative Liabilities
PHARMACYTE BIOTECH, INC. (PMCB) reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for the quarter ending 2024-01-31 was -$636.00K.
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-10-31 was $769.00K.
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-07-31 was $530.00K.
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. increase (decrease) in derivative liabilities for fiscal 2025 was $2.18M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 10-K · filed 2026-07-29 | |||
| 2025-04-30 | $2.18M 10-K · filed 2026-07-29 | |||
| 2024-01-31 | -$636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | $133.00K derived: sum of 2 quarters · filed 2024-03-18 | $663.00K 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | $1.30M 10-Q · filed 2023-12-15 | ||
| 2023-07-31 | $530.00K 10-Q · filed 2023-09-18 | |||
| 2023-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 10-Q · filed 2024-03-18 | |
| 2022-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | $0.00 10-Q · filed 2023-12-15 | ||
| 2022-07-31 | $0.00 10-Q · filed 2023-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |